Abstract
A40926 is a new glycopeptide antibiotic with unique activity against Neisseria gonorrhoeae and high and prolonged levels in mouse blood (B. P. Goldstein, E. Selva, L. Gastaldo, M. Berti, R. Pallanza, F. Ripamonti, P. Ferrari, M. Denaro, V. Arioli, and G. Cassani, Antimicrob. Agents Chemother., 31:1961-1966, 1987). We studied the pharmacokinetics of A40926 in rats after single intravenous and subcutaneous 10-mg/kg (body weight) doses. Concentrations in plasma and urine were determined by microbiological assay. After intravenous administration, high concentrations of A40926, ranging from 132 mg/liter at 3 min to 0.7 mg/liter at 96 h, were found in plasma. Concentrations declined with a three-exponential decay correlated with a prolonged, biphasic distribution and a slow elimination (terminal half-life, 61.22 h). After completion of the distribution, the compound was widely distributed to the extravascular space. The rate-limiting step in the elimination of A40926 from the body appears to be the slow return from the deep compartment into the central one. A40926 was rapidly absorbed from the injection site after subcutaneous administration, and its availability was close to 90%. The percentage of the dose excreted in urine in 120 h was 35.9%.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bernareggi A., Cavenaghi L., Assandri A. Pharmacokinetics of [14C]teicoplanin in male rats after single intravenous dose. Antimicrob Agents Chemother. 1986 Nov;30(5):733–738. doi: 10.1128/aac.30.5.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goldstein B. P., Selva E., Gastaldo L., Berti M., Pallanza R., Ripamonti F., Ferrari P., Denaro M., Arioli V., Cassani G. A40926, a new glycopeptide antibiotic with anti-Neisseria activity. Antimicrob Agents Chemother. 1987 Dec;31(12):1961–1966. doi: 10.1128/aac.31.12.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grappel S. F., Giovenella A. J., Phillips L., Pitkin D. H., Nisbet L. J. Antimicrobial activity of aridicins, novel glycopeptide antibiotics with high and prolonged levels in blood. Antimicrob Agents Chemother. 1985 Nov;28(5):660–662. doi: 10.1128/aac.28.5.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marre R., Schulz E., Anders T., Sack K. Renal tolerance and pharmacokinetics of vancomycin in rats. J Antimicrob Chemother. 1984 Sep;14(3):253–260. doi: 10.1093/jac/14.3.253. [DOI] [PubMed] [Google Scholar]
- Sitrin R. D., Chan G. W., Dingerdissen J. J., Holl W., Hoover J. R., Valenta J. R., Webb L., Snader K. M. Aridicins, novel glycopeptide antibiotics. II. Isolation and characterization. J Antibiot (Tokyo) 1985 May;38(5):561–571. doi: 10.7164/antibiotics.38.561. [DOI] [PubMed] [Google Scholar]
- Verbist L., Tjandramaga B., Hendrickx B., Van Hecken A., Van Melle P., Verbesselt R., Verhaegen J., De Schepper P. J. In vitro activity and human pharmacokinetics of teicoplanin. Antimicrob Agents Chemother. 1984 Dec;26(6):881–886. doi: 10.1128/aac.26.6.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weiner D. L. NONLIN84/PCNONLIN: software for the statistical analysis of nonlinear models. Methods Find Exp Clin Pharmacol. 1986 Oct;8(10):625–628. [PubMed] [Google Scholar]
- Yamaoka K., Nakagawa T., Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm. 1978 Apr;6(2):165–175. doi: 10.1007/BF01117450. [DOI] [PubMed] [Google Scholar]